Saturday, March 09, 2024 9:05:00 AM
Recent KPTI News
- Form SC TO-I/A - Tender offer statement by Issuer: [Amend] • Edgar (US Regulatory) • 07/19/2024 08:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:15:46 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 07/01/2024 08:05:00 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/20/2024 12:01:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/10/2024 04:15:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:03:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 08:02:21 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/03/2024 08:05:00 PM
- Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates • PR Newswire (US) • 06/01/2024 05:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 12:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:32:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 09:32:34 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/30/2024 08:44:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/30/2024 08:06:36 PM
- Karyopharm to Participate at the Jefferies Global Healthcare Conference • PR Newswire (US) • 05/29/2024 08:05:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/23/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:06:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:13:19 PM
- Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/08/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:52:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:47:54 AM
- Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress • PR Newswire (US) • 05/08/2024 11:30:00 AM
- Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029 • PR Newswire (US) • 05/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 08:56:19 PM
- Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024 • PR Newswire (US) • 05/02/2024 08:30:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM